Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Duodenal-jejunal bypass for the treatment of type 2 diabetes in Chinese patients with an average body mass index<24 kg/m2.
- F. Jiang, Hengliang Zhu, Xiaofeng Zheng, Jinfu Tu, Weijian Zhang, Xuemeng Xie
- Surgery for obesity and related diseases…
- 1 July 2014
DJB can improve glycemic control in nonobese T2DM patients without significant weight loss but may not be effective enough to induce remission of T2 DM in non obese Chinese patients. Expand
Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
- Bingren Hu, Huajie Cai, Ru Zheng, Shouzhang Yang, Zhenxu Zhou, Jinfu Tu
- Biology, Medicine
- The international journal of biochemistry & cell…
- 1 November 2017
The results provide the new evidence supporting the tumor-suppressive role of LINC00657 in HCC, suggesting that LINC 00657 might play a role in H CC and can be a novel therapeutic target for treating HCC. Expand
Berbamine Enhances the Efficacy of Gefitinib by Suppressing STAT3 Signaling in Pancreatic Cancer Cells
- Bingren Hu, Huajie Cai, Shouzhang Yang, Jinfu Tu, Xiaming Huang, G. Chen
- Chemistry, Medicine
- OncoTargets and therapy
- 24 December 2019
This study found that BBM synergizes with Gefi to inhibit cell growth and induce cell cycle arrest and PC cell apoptosis and suggests that the combination of BBM andGefi could be further developed as a potential PC therapy. Expand
Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer
- Xuemeng Xie, Jinfu Tu, Heyi You, Bingren Hu
- Chemistry, Medicine
- Drug design, development and therapy
- 12 May 2017
D6 may be a promising therapeutic agent for PC treatment and it provides a structural lead for the design of novel IKKβ inhibitors, as well as effectively inducing cancer cell apoptosis. Expand
Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis.
Bvacizumab is a valuable addition to the current first-line chemotherapy regimens used in patients with mCRC, because of conferring a significant improvement in ORR, PFS, and OS, even though it increased adverse events. Expand
LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values
SAMMSON negatively regulated miR-9-3p in HCC cells to promote cancer cell migration and invasion and patients with high levels of SAMMSON in H CC tissues had significantly lower overall rate within 5 years after admission. Expand
A predictive nomogram for lymph node metastasis of incidental gallbladder cancer: a SEER population-based study
The nomogram established in this study has good prediction ability and can effectively predict the risk of LNM and make up for the inaccuracy of imaging for patients with IGBC requiring re-resection. Expand
Design , synthesis , and biological evaluation of novel EF 24 and EF 31 analogs as potential i κ B kinase β inhibitors for the treatment of pancreatic cancer
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms.… Expand
[Zhu's trocar placement in laparoscopic appendectomy in the treatment of complicated appendicitis].
- Hengliang Zhu, Huaiming Wang, +4 authors Jinfu Tu
- Zhonghua wei chang wai ke za zhi = Chinese…
- 25 August 2018
ZTP-LA is safe, feasible and effective with advantages of faster recovery and less cost in the treatment of complicated appendicitis and lower postoperative morbidity of complication. Expand